The manufacturer of Insulin Glulisine (Apidra®) has written to healthcare professionals to advise that this product is now returning to stock.
The letter notes that the supply shortage that was announced in September 2011 was due to a technical incident at the manufacturing site. The current supply status is as follows:
- Apidra cartridges (for ClikStar) - expected to become available week commencing 6th February 2012
- Apidra SoloStar - expected to become available week commencing 6th February 2012
- Apidra vials - remain unaffected by the supply shortage
- Apidra Optiset - discontinued as planned with effect from 31st December 2011
- Aipdra cartridges (for OptiClik) - discontinued as planned with effect from 31st December 2011
Action: Clinicians should be aware that this product is now returning to stock. Supplies may be sporadic in early weeks as back orders are filled.